Today: 9 March 2026
Subscribe
Browse Category

Earnings Reports 9 January 2026

Astronics (ATRO) stock rises again after Q4 revenue update and 2026 sales forecast

Astronics (ATRO) stock rises again after Q4 revenue update and 2026 sales forecast

Astronics shares rose 1.7% to $65.88 Friday morning after the company reported unaudited fourth-quarter revenue of $236–$239 million, up 14% year-over-year. Bookings reached $257 million for the quarter, with 2025 orders at $924 million. Management projected 2026 revenue between $950 million and $990 million. The stock surpassed analysts’ average 12-month target price of $60.75.
9 January 2026
···
Barrick Mining stock price ticks up as gold steadies; U.S. jobs data and Feb. 5 results loom

Barrick Mining stock price ticks up as gold steadies; U.S. jobs data and Feb. 5 results loom

Barrick Mining shares rose 0.7% to $47.78 by 10:06 a.m. EST Friday as gold prices hovered near record highs. U.S. nonfarm payrolls increased by 50,000 in December, below forecasts, keeping attention on rates and the dollar. Barrick will report full-year and Q4 results on Feb. 5. Gold-backed ETFs saw $89 billion in inflows in 2025, lifting holdings to a record 4,025 tonnes.
9 January 2026
····
Neogen stock steadies near $10 after 32% surge on raised outlook; next catalyst is Jan. 14

Neogen stock steadies near $10 after 32% surge on raised outlook; next catalyst is Jan. 14

Neogen shares traded near $9.74 premarket Friday after surging 32% Thursday on raised fiscal 2026 revenue guidance to $845–$855 million. Quarterly revenue fell 2.8% to $224.7 million, topping estimates, while net loss reached $15.9 million. Gross margin dropped to 47.5%. CEO Mike Nassif said integration of Petrifilm and manufacturing changes are underway.
9 January 2026
··
Apple stock today: AAPL slips as Apple Card shifts to JPMorgan with earnings in view

Apple stock today: AAPL slips as Apple Card shifts to JPMorgan with earnings in view

Apple shares fell 0.5% to $259.04 early Friday after Apple and JPMorgan Chase announced Chase will take over as Apple Card issuer in a transition expected to last about 24 months. JPMorgan expects a $2.2 billion provision for credit losses tied to the deal. Investors await Apple’s Jan. 29 results for signals on holiday demand and services growth.
9 January 2026
····
BigBear.ai stock ticks up in premarket — here’s what’s driving BBAI and the two January dates ahead

BigBear.ai stock ticks up in premarket — here’s what’s driving BBAI and the two January dates ahead

BigBear.ai shares rose 3% to $6.17 in Friday premarket trading after a broker downgrade earlier in the week. Investors are watching a Jan. 16 note redemption and a Jan. 22 shareholder vote to double authorized shares. A law firm issued an investor alert Thursday, adding to legal uncertainty. The stock remains volatile, trading near key technical levels.
9 January 2026
··
GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK stock slips in London as hepatitis B drug details awaited; Feb 4 results loom

GSK shares slipped 0.6% to 1,879.5p in London by 10:50 GMT as investors awaited detailed data from its phase III hepatitis B drug trial. Analysts pressed for cure rate and durability figures after GSK withheld specifics. A royalty dispute over cancer drug Jemperli is pending in U.S. court, with a trial set for July 2026. Investors are watching for updates at the Jan. 13 J.P. Morgan conference and Feb. 4 results.
9 January 2026
···
UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

UnitedHealth stock rises as lawmakers summon insurers; UNH earnings date now in focus

U.S. House committees summoned UnitedHealth and four other insurers to testify on coverage affordability Jan. 22. UnitedHealth shares rose 1.5% to $346.85 after Wolfe Research raised its price target to $400. The company reports 2025 earnings and 2026 guidance Jan. 27. Senators also accused UnitedHealth of withholding documents in a nursing home care probe.
9 January 2026
·····
Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher stock slips again after the bell — here’s what traders are watching next for TMO

Thermo Fisher shares fell 1.7% to $606.50 Thursday, extending losses after reaching a 52-week high of $628.08 earlier in the week. Trading volume topped 3 million shares, nearly double the average. The company will present at the J.P. Morgan Healthcare Conference on Jan. 13 and report earnings Jan. 29. Investors await updates on the $8.9 billion Clario acquisition, expected to close by mid-2026.
9 January 2026
··
1 … 127 128 129 130 131 … 227
Go toTop